Silencing CK19 regulates ferroptosis by affecting the expression of GPX4 and ACSL4 in oral squamous cell carcinoma in vivo and in vitro
Open Access
- 10 July 2024
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 14 (1) , 1-12
Abstract
To analyze the mechanism of how interfering with the cytokeratin 19 (CK19) pathway via the ferroptosis pathway affects tumor biological behaviors in the process of oral squamous cell carcinoma (OSCC) development. TCGA was used to analyze the expression of CK19 in pan-cancer and head and neck squamous cell carcinoma (HNSC) and to explore the ferroptosis-related genes related to HNSC. The effect of silencing CK19 on the migration ability of HSC-4 cells was verified by wound healing and migration assay. HSC-4 cells with silencing of CK19 and tumor-bearing nude mouse model were constructed. RT-qPCR, immunofluorescence and western blot were used to analyze the expression of ferroptosis-related genes. CK19 is highly expressed in human OSCC and nude mice. The migration ability of cells in the CK19-silenced group was lower than that of the control group. In vivo and in vitro, CK19 was negatively correlated with the expression of ACSL4 and positively correlated with the expression of GPX4. Compared with the control group, GPX4 expression was down-regulated and ACSL4 expression was up-regulated in the CK19-silenced group. Silencing CK19 also increased intracellular Fe2+ content and MDA content. Silencing CK19 can affect the expression of GPX4 and ACSL4 to regulate ferroptosis and at the same time increase the content of MDA, Fe2+ and ROS levels, thereby activating the regulation of ferroptosis pathway in the development of OSCC.Keywords
Funding Information
- The Key program of applied basic Research of Southwest Medical University (2021ZKZD010)
- Science and Technology Program of Sichuan Province (2022NSFSC0716)
This publication has 45 references indexed in Scilit:
- Cytokeratin 19 as a biomarker of highly invasive oral squamous cell carcinoma with metastatic potentialJournal of Oral and Maxillofacial Surgery, Medicine, and Pathology, 2020
- Iron homeostasis and iron-regulated ROS in cell death, senescence and human diseasesBiochimica et Biophysica Acta (BBA) - General Subjects, 2019
- Targeting Ferroptosis to Iron Out CancerCancer Cell, 2019
- Evaluation of cytokeratin 19 as a prognostic tumoral and metastatic marker with focus on improved detection methodsJournal of Cellular Physiology, 2019
- A role for long-chain acyl-CoA synthetase-4 (ACSL4) in diet-induced phospholipid remodeling and obesity-associated adipocyte dysfunctionMolecular Metabolism, 2018
- Microbial antioxidant defense enzymesMicrobial Pathogenesis, 2017
- Overexpression of glutathione peroxidase 1 predicts poor prognosis in oral squamous cell carcinomaJournal of Cancer Research and Clinical Oncology, 2017
- Correlation of Cyfra 21-1 levels in saliva and serum with CK19 mRNA expression in oral squamous cell carcinomaTumor Biology, 2016
- Structural and functional characterization of Nrf2 degradation by glycogen synthase kinase 3/β-TrCPFree Radical Biology and Medicine, 2015
- Increased levels of CK19 mRNA in oral squamous cell carcinoma tissue detected by relative quantification with real-time polymerase chain reactionArchives of Oral Biology, 2006